206 related articles for article (PubMed ID: 30710161)
1. Elevated Bone Remodeling Markers of CTX and P1NP in Addition to Sclerostin in Patients with X-linked Hypophosphatemia: A Cross-Sectional Controlled Study.
Hansen S; Shanbhogue VV; Jørgensen NR; Beck-Nielsen SS
Calcif Tissue Int; 2019 Jun; 104(6):591-598. PubMed ID: 30710161
[TBL] [Abstract][Full Text] [Related]
2. Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnover.
van Lierop AH; Hamdy NA; Hamersma H; van Bezooijen RL; Power J; Loveridge N; Papapoulos SE
J Bone Miner Res; 2011 Dec; 26(12):2804-11. PubMed ID: 21786318
[TBL] [Abstract][Full Text] [Related]
3. 24-hour profile of serum sclerostin and its association with bone biomarkers in men.
Swanson C; Shea SA; Wolfe P; Markwardt S; Cain SW; Munch M; Czeisler CA; Orwoll ES; Buxton OM
Osteoporos Int; 2017 Nov; 28(11):3205-3213. PubMed ID: 28744601
[TBL] [Abstract][Full Text] [Related]
4. Low Levels of Serum Sclerostin in Adult Patients With Tumor-Induced Osteomalacia Compared With X-linked Hypophosphatemia.
Ni X; Zhang Q; Li X; Pang Q; Gong Y; Wang O; Li M; Xing X; Jiang Y; Xia W
J Clin Endocrinol Metab; 2022 Jan; 107(1):e361-e371. PubMed ID: 34363479
[TBL] [Abstract][Full Text] [Related]
5. Bone Turnover Status: Classification Model and Clinical Implications.
Fisher A; Fisher L; Srikusalanukul W; Smith PN
Int J Med Sci; 2018; 15(4):323-338. PubMed ID: 29511368
[No Abstract] [Full Text] [Related]
6. Serum Sclerostin and Its Association with Bone Turnover Marker in Metabolic Bone Diseases.
Chen L; Gao G; Shen L; Yue H; Zhang G; Zhang Z
Dis Markers; 2022; 2022():7902046. PubMed ID: 36124027
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Mild Autonomous Cortisol Secretion on Bone Turnover Markers.
Athimulam S; Delivanis D; Thomas M; Young WF; Khosla S; Drake MT; Bancos I
J Clin Endocrinol Metab; 2020 May; 105(5):1469-77. PubMed ID: 32154561
[TBL] [Abstract][Full Text] [Related]
8. Circulating sclerostin levels are decreased in patients with endogenous hypercortisolism and increase after treatment.
van Lierop AH; van der Eerden AW; Hamdy NA; Hermus AR; den Heijer M; Papapoulos SE
J Clin Endocrinol Metab; 2012 Oct; 97(10):E1953-7. PubMed ID: 22844062
[TBL] [Abstract][Full Text] [Related]
9. Sclerostin and bone turnover markers response to cycling and running at the same moderate-to-vigorous exercise intensity in healthy men.
Dror N; Carbone J; Haddad F; Falk B; Klentrou P; Radom-Aizik S
J Endocrinol Invest; 2022 Feb; 45(2):391-397. PubMed ID: 34390461
[TBL] [Abstract][Full Text] [Related]
10. Sleep Restriction With Circadian Disruption Negatively Alter Bone Turnover Markers in Women.
Swanson CM; Shea SA; Kohrt WM; Wright KP; Cain SW; Munch M; Vujović N; Czeisler CA; Orwoll ES; Buxton OM
J Clin Endocrinol Metab; 2020 Jul; 105(7):2456-63. PubMed ID: 32364602
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of bone markers in hypophosphatemic rickets/osteomalacia.
Nagata Y; Imanishi Y; Ishii A; Kurajoh M; Motoyama K; Morioka T; Naka H; Mori K; Miki T; Emoto M; Inaba M
Endocrine; 2011 Oct; 40(2):315-7. PubMed ID: 21822687
[TBL] [Abstract][Full Text] [Related]
12. Study of the distribution by age group of serum cross-linked C-terminal telopeptide of type I collagen and procollagen type I N-propeptide in healthy Japanese women to establish reference values.
Nomura Y; Yoshizaki A; Yoshikata H; Kikuchi R; Sakakibara H; Chaki O; Fukunaga M; Hirahara F
J Bone Miner Metab; 2013 Nov; 31(6):644-51. PubMed ID: 23579312
[TBL] [Abstract][Full Text] [Related]
13. The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study.
Zhao J; Xia W; Nie M; Zheng X; Wang Q; Wang X; Wang W; Ning Z; Huang W; Jiang Y; Li M; Wang O; Xing X; Sun Y; Luo L; He S; Yu W; Lin Q; Pei Y; Zhang F; Han Y; Tong Y; Che Y; Shen R; Hu Y; Zhou X; Xu L
Menopause; 2011 Nov; 18(11):1237-43. PubMed ID: 21747303
[TBL] [Abstract][Full Text] [Related]
14. Bone turnover markers in Spanish adult men The Camargo Cohort Study.
Olmos JM; Hernández JL; Martínez J; Pariente E; Llorca J; González-Macías J
Clin Chim Acta; 2010 Oct; 411(19-20):1511-5. PubMed ID: 20594548
[TBL] [Abstract][Full Text] [Related]
15. Upregulated serum sclerostin level in the T2DM patients with femur fracture inhibits the expression of bone formation/remodeling-associated biomarkers via antagonizing Wnt signaling.
Wu Y; Xu SY; Liu SY; Xu L; Deng SY; He YB; Xian SC; Liu YH; Ni GX
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):470-478. PubMed ID: 28239825
[TBL] [Abstract][Full Text] [Related]
16. Low serum levels of bone turnover markers are associated with the presence and severity of diabetic retinopathy in patients with type 2 diabetes mellitus.
An Y; Liu S; Wang W; Dong H; Zhao W; Ke J; Zhao D
J Diabetes; 2021 Feb; 13(2):111-123. PubMed ID: 32671958
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two automated assays of BTM (CTX and P1NP) and reference intervals in a Danish population.
Jørgensen NR; Møllehave LT; Hansen YBL; Quardon N; Lylloff L; Linneberg A
Osteoporos Int; 2017 Jul; 28(7):2103-2113. PubMed ID: 28455749
[TBL] [Abstract][Full Text] [Related]
18. Associations between Postprandial Gut Hormones and Markers of Bone Remodeling.
Jensen NW; Clemmensen KKB; Jensen MM; Pedersen H; Færch K; Diaz LJ; Quist JS; Størling J
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579074
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic Associations with Serum Bone Turnover Markers.
Bellissimo MP; Roberts JL; Jones DP; Liu KH; Taibl KR; Uppal K; Weitzmann MN; Pacifici R; Drissi H; Ziegler TR; Alvarez JA
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33081124
[TBL] [Abstract][Full Text] [Related]
20. Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men.
Shou Z; Jin X; Bian P; Li X; Chen J
Geriatr Gerontol Int; 2017 May; 17(5):773-778. PubMed ID: 27137883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
